Soluble neprilysin and survival in critically ill patients.
Max LenzKonstantin A KrychtiukMira BrekaloDominik F DraxlerNoemi PavoChristian HengstenbergKurt HuberMartin HülsmannGottfried HeinzJohann WojtaWalter S SpeidlPublished in: ESC heart failure (2022)
At the time of ICU admission, circulating levels of neprilysin independently predicted 30 day mortality in patients following cardiac surgery or heart valve intervention, but not in critically ill medical patients. Furthermore, patients suffering from sepsis and septic shock displayed significantly increased circulating neprilysin levels.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cardiac surgery
- septic shock
- intensive care unit
- randomized controlled trial
- emergency department
- heart failure
- acute kidney injury
- peritoneal dialysis
- cardiovascular disease
- patient reported outcomes
- aortic valve
- risk factors
- coronary artery disease
- patient reported
- transcatheter aortic valve replacement
- aortic stenosis